TSS
CDTX

Two Sigma Securities’s Cidara Therapeutics CDTX Stock Holding History

Two Sigma Securities’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,834
Closed -$29.1K – 3020
2023
Q4 		$29.1K Buy
+1,834
New +$29.5K ﹤0.01% 2669
2023
Q2 		– Sell
-580
Closed -$14.7K – 2824
2023
Q1 		$14.7K Buy
+580
New +$16.5K ﹤0.01% 2403
2022
Q4 		– Sell
-2,091
Closed -$26K – 2646
2022
Q3 		$26K Buy
+2,091
New +$28.9K ﹤0.01% 2268
2019
Q3 		– Sell
-645
Closed -$22K – 2086
2019
Q2 		$22K Buy
+645
New +$26.8K ﹤0.01% 1939

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Two Sigma Securities's CDTX Position: Q1 2024 in Review

Two Sigma Securities sold out of Cidara Therapeutics (CDTX) in Q1 2024, closing a stake of 1,834 shares — an estimated $29.1K sold.

Two Sigma Securities first reported a position in CDTX in Q2 2019 and held it in 4 quarters. The position peaked at $29.1K in Q4 2023. 50 funds tracked by Wall St. Rank hold CDTX as of Q1 2024.

  • Two Sigma Securities reported no remaining Cidara Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 1,834 Cidara Therapeutics shares in Q1 2024, an estimated $29.1K.
  • Two Sigma Securities first reported a position in Cidara Therapeutics in Q2 2019 and held it in 4 quarters.
  • Two Sigma Securities's Cidara Therapeutics position peaked at $29.1K in Q4 2023.
  • 50 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.